ALNY vs MD · P/E 76, rev $1.29B vs P/E 11, rev $964.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MD revenue for 2026-06-30 was $964.0M. Net income was $69.4M. MD currently screens at market cap $1.93B and trailing P/E 11.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MD currently screens at market cap $1.93B and trailing P/E 11.4.
Not investment advice. Open the ALNY and MD stock pages for the full models.
Not investment advice.